Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Halosense is a private Canadian consumer health and medical device company focused on home salt therapy and related breathing-support products. The company markets SaltAir ultrasonic air salinizer devices and complementary respiratory-care accessories intended to bring halotherapy into the home environment. Its products are positioned as natural, drug-free, non-invasive solutions for respiratory wellness, with additional wellness-oriented claims around skin and mental well-being. Halosense appears to operate primarily as a commercial device seller rather than a therapeutics developer, and there is no evidence of a traditional biotech or pharma drug pipeline. The business is based in London, Ontario and sells through SalineTherapy.com.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Halosense.